ClinicalTrials.gov
public full text
Public Domain
Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration
The purpose of this study is to determine whether Allogeneic Cardiosphere-Derived Cells (CAP-1002) is safe and effective in decreasing infarct size in patients with a myocardial infarction.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells#1434011
- Harvest, Isolation and Culture of Cardiac Stem Cells From Endomyocardial Biopsies#806218
- Minimizing time in culture: A prototypic autologous manufacturing workflow for monoclonal iPSC lines within seven weeks#1181749
- CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.#160363
- Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment#645093
Record · ID 1465214
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive